BriaCell Therapeutics Corp Archives - Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics in $3 Million Public Offering

By Sichenzia Ross Ference LLP | February 6, 2025

BriaCell Therapeutics

$3,000,000

Public Offering

February 2025

Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.5 Million Public Offering

By Sichenzia Ross Ference LLP | December 12, 2024

BriaCell Therapeutics

$5,500,000

Public Offering

December 2024

Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering

By Sichenzia Ross Ference LLP | October 2, 2024

BriaCell Therapeutics

$5,000,000

Common Stock and Warrants

October 2024

Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $8.5 Million Offering

By Sichenzia Ross Ference LLP | September 13, 2024

BriaCell Therapeutics

$8,500,000

Registered Offering

September 2024

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics Corp. in $5 Million Registered Direct Offering

By Sichenzia Ross Ference LLP | May 20, 2024

Press Release – New York, NY – May 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in a $5 million registered direct offering. The Company sold an aggregate of 2,402,935 common…